Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Holt

Showing results (201-210 of 273) with videos related to

Pageof 28
Sort By:
Arthritis and Rheumatism|May 19, 2000
Rofecoxib, a specific inhibitor of cyclooxygenase 2, with clinical efficacy comparable with that of diclofenac sodium: results of a one-year, randomized, clinical trial in patients with osteoarthritis of the knee and hip. Rofecoxib Phase III Protocol 035 Study GroupG W Cannon, J R Caldwell, P Holt, et al.
Chemmedchem|April 1, 2021
Structural Basis of Prolyl Hydroxylase Domain Inhibition by MolidustatWilliam D Figg, Michael A McDonough, Rasheduzzaman Chowdhury, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|December 17, 2011
PET Imaging of nicotinic acetylcholine receptors in baboons with 18F-AZAN, a radioligand with improved brain kineticsHiroto Kuwabara, Dean F Wong, Yongjun Gao, et al.
Medchemcomm|May 7, 2019
Studies on spiro[4.5]decanone prolyl hydroxylase domain inhibitorsJames P Holt-Martyn, Anthony Tumber, Mohammed Z Rahman, et al.
Bioorganic & Medicinal Chemistry|March 11, 2011
Synthesis and in vivo evaluation of (S)-6-(4-fluorophenoxy)-3-((1-[11C]methylpiperidin-3-yl)methyl)-2-o-tolylquinazolin-4(3H)-one, a potential PET tracer for growth hormone secretagogue receptor (GHSR)Rachel Potter, Andrew G Horti, Hayden T Ravert, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|June 17, 2008
In vivo PET imaging of cardiac presynaptic sympathoneuronal mechanisms in the ratDnyanesh N Tipre, James J Fox, Daniel P Holt, et al.
Circulation. Cardiovascular Imaging|August 7, 2015
Mechanistic Insights into Sympathetic Neuronal Regeneration: Multitracer Molecular Imaging of Catecholamine Handling After Cardiac TransplantationPaco E Bravo, Riikka Lautamäki, Debra Carter, et al.
British Journal of Anaesthesia|September 1, 2017
Use of failure-to-rescue to identify international variation in postoperative care in low-, middle- and high-income countries: a 7-day cohort study of elective surgeryT Ahmad, R A Bouwman, I Grigoras, et al.
Neuroimage|April 24, 2007
Using a reference tissue model with spatial constraint to quantify [11C]Pittsburgh compound B PET for early diagnosis of Alzheimer's diseaseYun Zhou, Susan M Resnick, Weiguo Ye, et al.
Bioorganic & Medicinal Chemistry Letters|October 22, 2008
New synthesis and evaluation of enantiomers of 7-methyl-2-exo-(3'-iodo-5'-pyridinyl)-7-azabicyclo[2.2.1]heptane as stereoselective ligands for PET imaging of nicotinic acetylcholine receptorsYongjun Gao, Andrew G Horti, Hiroto Kuwabara, et al.
Pageof 28

Showing results (201-210 of 273) with videos related to

Sort By:
Pageof 28
Arthritis and Rheumatism|May 19, 2000
Rofecoxib, a specific inhibitor of cyclooxygenase 2, with clinical efficacy comparable with that of diclofenac sodium: results of a one-year, randomized, clinical trial in patients with osteoarthritis of the knee and hip. Rofecoxib Phase III Protocol 035 Study GroupG W Cannon, J R Caldwell, P Holt, et al.
Chemmedchem|April 1, 2021
Structural Basis of Prolyl Hydroxylase Domain Inhibition by MolidustatWilliam D Figg, Michael A McDonough, Rasheduzzaman Chowdhury, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|December 17, 2011
PET Imaging of nicotinic acetylcholine receptors in baboons with 18F-AZAN, a radioligand with improved brain kineticsHiroto Kuwabara, Dean F Wong, Yongjun Gao, et al.
Medchemcomm|May 7, 2019
Studies on spiro[4.5]decanone prolyl hydroxylase domain inhibitorsJames P Holt-Martyn, Anthony Tumber, Mohammed Z Rahman, et al.
Bioorganic & Medicinal Chemistry|March 11, 2011
Synthesis and in vivo evaluation of (S)-6-(4-fluorophenoxy)-3-((1-[11C]methylpiperidin-3-yl)methyl)-2-o-tolylquinazolin-4(3H)-one, a potential PET tracer for growth hormone secretagogue receptor (GHSR)Rachel Potter, Andrew G Horti, Hayden T Ravert, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|June 17, 2008
In vivo PET imaging of cardiac presynaptic sympathoneuronal mechanisms in the ratDnyanesh N Tipre, James J Fox, Daniel P Holt, et al.
Circulation. Cardiovascular Imaging|August 7, 2015
Mechanistic Insights into Sympathetic Neuronal Regeneration: Multitracer Molecular Imaging of Catecholamine Handling After Cardiac TransplantationPaco E Bravo, Riikka Lautamäki, Debra Carter, et al.
British Journal of Anaesthesia|September 1, 2017
Use of failure-to-rescue to identify international variation in postoperative care in low-, middle- and high-income countries: a 7-day cohort study of elective surgeryT Ahmad, R A Bouwman, I Grigoras, et al.
Neuroimage|April 24, 2007
Using a reference tissue model with spatial constraint to quantify [11C]Pittsburgh compound B PET for early diagnosis of Alzheimer's diseaseYun Zhou, Susan M Resnick, Weiguo Ye, et al.
Bioorganic & Medicinal Chemistry Letters|October 22, 2008
New synthesis and evaluation of enantiomers of 7-methyl-2-exo-(3'-iodo-5'-pyridinyl)-7-azabicyclo[2.2.1]heptane as stereoselective ligands for PET imaging of nicotinic acetylcholine receptorsYongjun Gao, Andrew G Horti, Hiroto Kuwabara, et al.
Pageof 28